summary
Introduced
02/06/2025
02/06/2025
In Committee
02/06/2025
02/06/2025
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Creates the Access to Prescription Drugs Act. Provides that any State agency may enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs; to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers; and to increase patient access to affordable drugs. Requires the partnerships to result in the production or distribution of generic prescription drugs with the intent that these drugs be made widely available to public and private purchasers, providers and suppliers, and pharmacies. Provides that the State agency shall comply with specified requirements when entering into partnerships or setting prices for generic prescription drugs. Requires a State agency that elects to enter into a partnership under the Act to submit separate reports to the General Assembly that (1) assess the feasibility of directly manufacturing generic prescription drugs and selling generic prescription drugs at a fair price; and (2) describe the status of all drugs targeted under the Act and analyze how the activities of the State agency may impact competition, access to targeted drugs, the costs of those drugs, and the costs of generic prescription drugs to public and private purchasers. Contains other provisions. Amends the Freedom of Information Act to exempt certain information disclosed under Access to Prescription Drugs Act from inspection and copying under the Act. Contains a severability provision. Effective July 1, 2025.
AI Summary
This bill creates the Access to Prescription Drugs Act, which authorizes state agencies in Illinois to enter into partnerships aimed at increasing competition, lowering prices, and addressing shortages in the generic prescription drug market. The bill allows state departments to collaborate with drug manufacturers to produce or distribute generic prescription drugs at affordable prices, with a focus on medications for chronic and high-cost conditions. Key provisions include requirements for how departments should set drug prices, considering factors such as production costs, research expenses, and administrative overhead, while ensuring transparency and no hidden rebates. The bill mandates that departments consult with various public and private purchasers to identify which generic drugs to target and requires two important reports: one by July 1, 2027, assessing the feasibility of directly manufacturing generic drugs, and another by July 1, 2026, analyzing the potential impacts of these partnerships on drug competition, access, and costs. Notably, the bill includes a provision to protect non-public information related to these drug manufacturing efforts from public disclosure and specifically requires that at least one form of insulin be considered for production if a viable manufacturing pathway exists. The act is set to take effect on July 1, 2025, and aims to make prescription drugs more affordable and accessible for Illinois residents.
Sponsors (1)
Last Action
Referred to Assignments (on 02/06/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1907&GAID=18&DocTypeID=SB&SessionID=114&GA=104 |
| BillText | https://www.ilga.gov/legislation/104/SB/10400SB1907.htm |
Loading...